Gyre Therapeutics Inc. (GYRE)
NASDAQ: GYRE
· Real-Time Price · USD
8.11
-0.11 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
8.14
0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT
Gyre Therapeutics Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 102.19M | 100.64M | 105.76M | 105.03M | 111.59M | 112.5M | 109.76M | 81.82M | 78.95M | 76.15M | 52.5M | 55.74M | 28.87M | 6.67M | 7.34M | 6.93M | 5.52M | 6.05M |
Cost of Revenue | 4.18M | 3.8M | 3.88M | 3.96M | 4.18M | 3.73M | 3.34M | 2.89M | 2.51M | 2.26M | 2.47M | 4.12M | 5.63M | 6.7M | 7.38M | 6.96M | 5.56M | 6.16M |
Gross Profit | 98.01M | 96.84M | 101.87M | 101.08M | 107.4M | 108.77M | 106.42M | 78.93M | 76.44M | 73.89M | 50.04M | 51.62M | 23.24M | -33K | -42K | -28K | -38K | -115K |
Operating Income | 9.27M | 10.37M | 16.16M | -76.07M | -67.53M | -73.34M | -81.23M | -29.88M | -47.8M | 6.27M | -8.61M | 11.35M | -8.71M | -80.16M | -87.89M | -86.42M | -77.29M | -74.74M |
Interest Income | 1.07M | 1.42M | 1.55M | 1.73M | 1.49M | 1.14M | 907.63K | 546K | 546K | 648K | 552K | 389K | 113K | 22K | 39K | 60K | 127K | 244K |
Pretax Income | 11.57M | 15.37M | 23.22M | -77.83M | -70.57M | -79.08M | -91.29M | -31.11M | -47.19M | 6.92M | -7.89M | 11.88M | -8.47M | -80.03M | -87.93M | -86.51M | -77.31M | -74.63M |
Net Income | 8.04M | 11.13M | 15.96M | -36.13M | -37.16M | -35.09M | -37.25M | 11.46M | 4.15M | 3.32M | 2.99M | -13.86M | -35.76M | -60.46M | -87.93M | -86.51M | -77.31M | -74.63M |
Selling & General & Admin | 75.66M | 73.48M | 73.62M | 77.82M | 75.38M | 77.25M | 75.82M | 53.47M | 42.74M | 26.88M | 27.08M | 27.08M | 27.59M | 28.26M | 18.96M | 19.08M | 18.05M | 17.9M |
Research & Development | 13.01M | 12.94M | 12.02M | 95.98M | 96.22M | 93.18M | 91.59M | 4.58M | 2.37M | 3.92M | 13.04M | 28.51M | 48.06M | 61.58M | 68.89M | 67.31M | 59.21M | 56.72M |
Other Expenses | 67K | 66K | 66K | 3.34M | 3.34M | 3.97M | 3.92M | 579.3K | 579.3K | -32.7K | n/a | -20K | -36K | -78K | -78K | -149K | -140K | -130K |
Operating Expenses | 88.73M | 86.48M | 85.71M | 177.14M | 174.94M | 156.29M | 142.72M | 30.02M | 17.09M | 20.26M | 30.4M | 45.88M | 65.93M | 80.12M | 87.85M | 86.39M | 77.25M | 74.63M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 716K | 717K | 819K | 832.68K | 116.68K | 115.68K | 13.68K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 56.59M | 55.81M | 57.51M | 57.12M | 57.35M | 60.93M | 61.16M | 44.7M | 30.77M | 12.77M | 12.71M | 12.71M | 12.71M | 12.71M | n/a | n/a | n/a | n/a |
Cost & Expenses | 92.92M | 90.28M | 89.59M | 181.1M | 179.12M | 159.7M | 145.16M | 31.2M | 17.09M | 20.26M | 31.2M | 49.13M | 71.49M | 86.82M | 95.23M | 93.35M | 82.82M | 80.79M |
Income Tax Expense | -1.11M | -275K | 3.17M | 3.67M | 8.42M | 6.92M | 4.39M | 4.04M | 82K | -57.27M | -57.46M | -57.81M | -57.54M | -204K | -39K | -60K | -127K | -244K |
Shares Outstanding (Basic) | 89.12M | 86.42M | 85.09M | 85.64M | 85.5M | 83.27M | 76.6M | 76.6M | 69.95M | 69.95M | 63.3M | 61.05M | 62.94M | 62.91M | 31.42M | 31.38M | 31.14M | 28.39M |
Shares Outstanding (Diluted) | 102.7M | 101.97M | 102.29M | 102.64M | 104.33M | 102.59M | 76.6M | 76.6M | 70.09M | 70.09M | 63.59M | 61.05M | 62.94M | 62.91M | 31.42M | 31.38M | 31.35M | 28.39M |
EPS (Basic) | -0.07 | -0.06 | 0.00 | -0.49 | -0.5 | -0.46 | -0.47 | 0.15 | 0.05 | 0.04 | 0.05 | -0.55 | -1.29 | -2.01 | -2.88 | -3.08 | -3.01 | -3.33 |
EPS (Diluted) | -0.08 | -0.07 | -0.00 | -0.52 | -0.52 | -0.47 | -0.47 | 0.15 | 0.05 | 0.04 | 0.05 | -0.55 | -1.29 | -2.01 | -2.88 | -3.08 | -3.01 | -3.33 |
EBITDA | 10.52M | 11.78M | 17.47M | 18.68M | 27.41M | 21.37M | 13.15M | -29.39M | -47.2M | 7.04M | -8.01M | 11.89M | -8.41M | -79.98M | -87.6M | -86.2M | -77.12M | -74.58M |
EBIT | 9.41M | 10.43M | 16.23M | 17.83M | 26.36M | 20.63M | 12.84M | -29.54M | -47.19M | 6.92M | 14.59M | 34.36M | 14.01M | -57.55M | -87.93M | -86.51M | -77.31M | -74.63M |
Depreciation & Amortization | 1.46M | 1.7M | 1.59M | 1.3M | 1.05M | 811.28K | 389.28K | 216K | 54K | 120K | 230K | 335K | 380K | 358K | 290K | 220K | 177K | 158K |